Patent details

LUC00036 Product Name: Trifluridine combinée au tipiracil ou un sel de tipiracil tel que l'hydrochlorure de tipiracil

Basic Information

Publication number:
LUC00036
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP067122929
Legal Status:
Active
Application number:
LUC00036
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/16/1096
Marketing Authorization Type:
Marketing Authorization Date:
27/04/2016
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
29/09/2017
First Marketing Authorization date:
27/04/2016
Grant date:
01/12/2017
Activation date:
Publication date:
02/10/2017
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
25/01/2031
SPC Extension Expiration:
25/01/2031
Rejection date:
Withdrawal date:

Owner

From:
29/09/2017
 
 

Name:
Taiho Pharmaceutical Co., Ltd.
Address:
1-27 Kandanishiki-cho, Chiyoda-ku Tokyo 101-8444, Japan (JP)

Agent

Name:
ARONOVA S.A.
From:
29/09/2017
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2017/07
Publication date:
11/12/2017
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC2
Bulletin edition number:
2018/02
Publication date:
15/01/2018
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
01/02/2027
Annual Fee Number:
22
Annual Fee Amount:
420 Euro
Expected Payer:
Last Annual Fee Payment Date:
16/01/2026
Last Annual Fee Paid Number:
21
Last Annual Fee Paid Amount:
410 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
29/09/2017 General Document 4
01/12/2017 Publication 1
29/09/2017 Application Form 4
01/12/2017 FNET_DC_FRONTPAGE 1
01/12/2017 Certificate 1
02/10/2017 Outgoing Correspondence 1
29/09/2017 General Document 2
29/09/2017 General Document 44
29/09/2017 General Document 6
02/10/2017 Publication 1